ACN(ACN)
ACN
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $73.64B | $76.65B | $80.70B | $91.62B | $99.63B |
| Low | $73.29B | $75.22B | $80.64B | $90.54B | $98.47B |
| High | $74.09B | $78.29B | $80.76B | $93.21B | $101.37B |
| EBITDA Avg | $12.84B | $13.36B | $14.07B | $15.97B | $17.37B |
| Low | $12.77B | $13.11B | $14.06B | $15.78B | $17.16B |
| High | $12.91B | $13.65B | $14.08B | $16.25B | $17.67B |
| EBIT Avg | $11.03B | $11.48B | $12.09B | $13.73B | $14.93B |
| Low | $10.98B | $11.27B | $12.08B | $13.57B | $14.75B |
| High | $11.10B | $11.73B | $12.10B | $13.97B | $15.19B |
| Net Income Avg | $8.74B | $9.01B | $9.72B | $11.56B | $11.83B |
| Low | $8.66B | $8.81B | $9.22B | $11.38B | $11.65B |
| High | $8.81B | $9.56B | $10.51B | $11.82B | $12.10B |
| EPS Avg | $13.86 | $14.65 | $15.71 | $18.28 | $18.71 |
| Low | $13.70 | $13.93 | $14.58 | $18.00 | $18.42 |
| High | $13.94 | $15.12 | $16.62 | $18.69 | $19.13 |
| Analysts (Rev / EPS) | 18 / 16 | 20 / 18 | 18 / 11 | 9 / 4 | 17 / 4 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $18.05B | $19.42B | $18.70B | $19.51B | $18.95B | $20.58B | $19.83B | $20.68B |
| Low | $17.95B | $19.36B | $18.48B | $19.28B | $18.73B | $20.34B | $19.60B | $20.44B |
| High | $18.12B | $19.51B | $18.92B | $19.74B | $19.17B | $20.82B | $20.06B | $20.92B |
| EBITDA Avg | $3.15B | $3.38B | $3.26B | $3.40B | $3.30B | $3.59B | $3.46B | $3.60B |
| Low | $3.13B | $3.37B | $3.22B | $3.36B | $3.26B | $3.55B | $3.42B | $3.56B |
| High | $3.16B | $3.40B | $3.30B | $3.44B | $3.34B | $3.63B | $3.50B | $3.65B |
| EBIT Avg | $2.71B | $2.91B | $2.80B | $2.92B | $2.84B | $3.08B | $2.97B | $3.10B |
| Low | $2.69B | $2.90B | $2.77B | $2.89B | $2.81B | $3.05B | $2.94B | $3.06B |
| High | $2.72B | $2.92B | $2.83B | $2.96B | $2.87B | $3.12B | $3.01B | $3.13B |
| Net Income Avg | $1.96B | $2.46B | $1.95B | $2.47B | $2.14B | $2.64B | $2.18B | $2.72B |
| Low | $1.92B | $2.37B | $1.92B | $2.43B | $2.11B | $2.60B | $2.15B | $2.68B |
| High | $2.05B | $2.56B | $1.98B | $2.51B | $2.17B | $2.68B | $2.21B | $2.76B |
| EPS Avg | $3.18 | $3.99 | $3.16 | $4.01 | $3.48 | $4.28 | $3.54 | $4.42 |
| Low | $3.12 | $3.85 | $3.11 | $3.95 | $3.42 | $4.22 | $3.49 | $4.35 |
| High | $3.33 | $4.15 | $3.21 | $4.07 | $3.53 | $4.35 | $3.59 | $4.48 |
| Analysts (Rev / EPS) | 11 / 14 | 11 / 12 | 5 / 7 | 6 / 10 | 9 / 10 | 5 / 9 | 4 / 6 | 6 / 6 |